Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Amoxicillin 125mg/5ml oral suspension sugar free
0501013B0AAASAS
|
Amoxicillin | Amoxicillin | Infections | 63,949 |
|
Trimethoprim 50mg/5ml oral suspension sugar free
0501080W0AAAIAI
|
Trimethoprim | Trimethoprim | Infections | 62,891 |
|
Ciprofloxacin 500mg tablets
0501120L0AAAFAF
|
Ciprofloxacin (Systemic) | Ciprofloxacin | Infections | 60,454 |
|
Erythromycin 250mg gastro-resistant tablets
0501050C0AAABAB
|
Erythromycin (Systemic) | Erythromycin | Infections | 59,172 |
|
Quinine bisulfate 300mg tablets
0504010T0AAAEAE
|
Quinine bisulfate | Quinine bisulfate | Infections | 58,137 |
|
Aciclovir 200mg tablets
0503021C0AAABAB
|
Aciclovir (Systemic) | Aciclovir | Infections | 55,058 |
|
Nystan 100,000units/ml oral suspension (ready mixed)
0502030B0BBABAB
|
Nystan (Systemic) | Nystatin | Infections | 54,689 |
|
Phenoxymethylpenicillin 250mg/5ml oral solution
0501011P0AAAFAF
|
Phenoxymethylpenicillin (Penicillin V) | Phenoxymethylpenicillin (Penicillin V) | Infections | 53,882 |
|
Nitrofurantoin 50mg capsules
0501130R0AAAAAA
|
Nitrofurantoin | Nitrofurantoin | Infections | 52,282 |
|
Cefalexin 250mg capsules
0501021L0AAAAAA
|
Cefalexin | Cefalexin | Infections | 51,960 |
|
Fluconazole 50mg capsules
0502010B0AAAAAA
|
Fluconazole | Fluconazole | Infections | 51,115 |
|
Nitrofurantoin 50mg tablets
0501130R0AAADAD
|
Nitrofurantoin | Nitrofurantoin | Infections | 50,613 |
|
Flucloxacillin 125mg/5ml oral solution
0501012G0AAAFAF
|
Flucloxacillin sodium | Flucloxacillin sodium | Infections | 47,869 |
|
Co-trimoxazole 80mg/400mg tablets
0501080D0AAAHAH
|
Co-trimoxazole | Co-trimoxazole(Trimethoprim/sulfamethoxazole) | Infections | 44,825 |
|
Clarithromycin 125mg/5ml oral suspension
0501050B0AAABAB
|
Clarithromycin | Clarithromycin | Infections | 44,752 |
|
Oxytetracycline 250mg tablets
0501030T0AAAJAJ
|
Oxytetracycline (Systemic) | Oxytetracycline | Infections | 43,023 |
|
Flucloxacillin 250mg capsules
0501012G0AAAAAA
|
Flucloxacillin sodium | Flucloxacillin sodium | Infections | 41,702 |
|
Azithromycin 500mg tablets
0501050A0AAADAD
|
Azithromycin | Azithromycin | Infections | 39,522 |
|
Fosfomycin 3g granules for oral solution sachets
0501070AEAAADAD
|
Fosfomycin trometamol | Fosfomycin trometamol | Infections | 37,429 |
|
Flucloxacillin 250mg/5ml oral solution
0501012G0AAAGAG
|
Flucloxacillin sodium | Flucloxacillin sodium | Infections | 36,497 |
|
Azithromycin 250mg capsules
0501050A0AAAAAA
|
Azithromycin | Azithromycin | Infections | 35,234 |
|
Clarithromycin 250mg tablets
0501050B0AAAAAA
|
Clarithromycin | Clarithromycin | Infections | 35,057 |
|
Rifaximin 550mg tablets
0501070X0AAABAB
|
Rifaximin | Rifaximin | Infections | 34,286 |
|
Amoxicillin 125mg/5ml oral suspension
0501013B0AAAJAJ
|
Amoxicillin | Amoxicillin | Infections | 27,883 |
|
Clarithromycin 250mg/5ml oral suspension
0501050B0AAAHAH
|
Clarithromycin | Clarithromycin | Infections | 27,436 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.